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Abstract
Background: The differentiation of naive T and B cells into memory lymphocytes is essential for
immunity to pathogens. Therapeutic manipulation of this cellular differentiation program could
improve vaccine efficacy and the in vitro expansion of memory cells. However, chemical screens
to identify compounds that induce memory differentiation have been limited by 1) the lack of
reporter-gene or functional assays that can distinguish naive and memory-phenotype T cells at high
throughput and 2) a suitable cell-line representative of naive T cells.
Results: Here, we describe a method for gene-expression based screening that allows primary
naive and memory-phenotype lymphocytes to be discriminated based on complex genes signatures
corresponding to these differentiation states. We used ligation-mediated amplification and a
fluorescent, bead-based detection system to quantify simultaneously 55 transcripts representing
naive and memory-phenotype signatures in purified populations of human T cells. The use of a
multi-gene panel allowed better resolution than any constituent single gene. The method was
precise, correlated well with Affymetrix microarray data, and could be easily scaled up for high-
throughput.
Conclusion: This method provides a generic solution for high-throughput differentiation screens
in primary human T cells where no single-gene or functional assay is available. This screening
platform will allow the identification of small molecules, genes or soluble factors that direct
memory differentiation in naive human lymphocytes.
Background
After antigen encounter populations of naive lymphocytes
cells differentiate through an effector state into memory
cells that confer protective immunity to the host [1,2].
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Memory lymphocytes acquire functions during this differ-
entiation process that are necessary for their immunologic
efficacy, including a lowered threshold for proliferation
and acquisition of effector functions, and the ability to
self-renew for the life-time of the host.
Historically, vaccines have been used to induce antigen-
specific T and B cell memory and are highly effective
against many pathogens [3]. However, diseases like HIV
and cancer that are characterized by defective T cell func-
tion are refractory to current vaccination approaches [4,5].
The ability to manipulate directly the differentiation of
memory lymphocytes would therefore have great impor-
tance in improving immunotherapies for cancer and
chronic viral diseases. However, the regulatory mecha-
nisms that govern the differentiation of naive lym-
phocytes into memory cells are not completely
understood. This has precluded the development of tar-
geted therapies that could influence the cellular differenti-
ation program underlying memory development [2].
High-throughput small-molecule screens are being
increasingly used as a tool to identify compounds that can
direct cellular differentiation from a precursor cell into a
more differentiated cell-type [6]. This raises the possibility
that similar approaches could be used to identify small
molecules that induce the full or partial differentiation of
naive cells into those that have functional characteristics
of memory cells. Small molecules capable of promoting
memory differentiation could 1) serve as tool compounds
to understand better memory differentiation: and 2) have
therapeutic applications in the ex-vivo expansion of anti-
gen-specific T cells or as molecularly targeted vaccine
adjuvants. Applying this approach to memory differentia-
tion, however, is limited by significant obstacles. Differen-
tiation screens rely on high-throughput assays that can
detect the emergence of a more differentiated state. This is
often achieved by the use of a reporter gene assay that
monitors the expression level of a single differentiation
marker gene [7,8]. Reporter gene screens have been used
to identify compounds that partially induce either neural
or cardiac differentiation in an undifferentiated cell line.
However, the memory lymphocyte pool is highly hetero-
geneous, and no single gene can reliably distinguish naive
and memory lymphocytes [1]. Other screening
approaches have assayed for a functional read-out such as
proliferation to detect compounds that promote a more
differentiated state in neural precursor cells [9], but the
cardinal functional characteristics of memory cells such as
longevity and the ability to self-renew are not easily
assayed in vitro.
Genome-wide transcriptional profiling of naive, effector
and memory T cells has demonstrated that extensive
reprogramming of gene expression occurs during memory
differentiation [10,11]. We have previously used cross-
species genomic analysis to identify the transcriptional
programs that occur during memory differentiation in
humans and mice [12]. We demonstrated that these coor-
dinately regulated transcriptional programs, or differenti-
ation signatures, are highly evolutionarily conserved, and
shared by multiple lymphoid lineages [12]. This suggests
that although no single gene can serve as a marker for
memory differentiation, a complex signature of genes may
be used to identify populations of cells that have adopted
a differentiation state of interest. We therefore sought to
develop a robust assay that could discriminate between
naive and memory states in primary human lymphocytes
based not on a single reporter gene, but on a complex
gene expression profile. Previous work in cancer cell lines
has demonstrated the utility of using a complex gene
expression signature to detect cellular differentiation
[13,14]. We therefore tested whether a gene expression-
based assay could be used as a high-throughput assay to
distinguish primary human naive and memory-pheno-
type T cells.
Results
Detection of differentiation signatures by ligation-
mediated amplification
Ligation-mediated amplification with bead-based detec-
tion has been described in detail previously [14-16]. In
brief, mRNAs are captured on oligo-dT-coated 384-well
plates and reverse transcribed to generate first strand
cDNA covalently linked to the plate (Fig. 1). Gene-specific
20-mer oligonucleotides corresponding to the signature
genes are then annealed to the cDNA template. The oligos
are designed in such a way that primer pairs anneal to
adjacent stretches of the gene, allowing the ends of the
primer pairs to abut. This is necessary for the ligation step,
which will only occur when the abutting ends of the
primer pairs are held adjacent to each other by binding
the corresponding cDNA. Both gene-specific oligos incor-
porate a common flanking sequence that allows PCR
amplification using a single set of PCR primers that will
amplify all gene-specific amplicons. This amplification
technique enables the simultaneous amplification of the
signature transcripts in a highly reproducible manner that
is faithful to the relative abundance of the starting
mRNAs. To resolve the relative amounts of each gene-spe-
cific amplicon, one partner of each of the oligo pairs
incorporates a unique barcode sequence that binds to a
fluorescent bead linked to an oligo with a corresponding
antisense sequence. Following PCR amplification, indi-
vidual gene-specific amplicons are distinguished by the
fluorescence emission spectra of the barcode-oligo-tagged
beads to which they bind. To identify how much ampli-
con is bound to each bead, one of the PCR primers is
biotinylated to allow detection of the relative abundance
of the amplicon bound to each bead using streptavidin-BMC Immunology 2008, 9:44 http://www.biomedcentral.com/1471-2172/9/44
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phycoerythrin. Up to 100 fluorescently distinct beads are
used allowing the quantitation of transcripts from up to
100 genes. The emission spectrum of each bead denotes
the identity of the gene; the phycoerythrin intensity the
transcript's abundance.
Selection of Marker Genes to Distinguish Naive and 
Memory-Phenotype CD4 T cells
As proof of principle, we tested whether we could use this
approach to distinguish between naive human CD4 cells
and memory-phenotype cells on the basis of a well-
defined differentiation signature. To identify a differentia-
tion signature that was characteristic of the memory state,
we analyzed our previously-published gene expression
profiles of human and mouse memory lymphocytes [12].
In a two-step analytic process, we first identified a set of
genes differentially expressed by human memory-pheno-
type CD4 T cells compared to their naive precursors (Fig
2.). Then, we refined this list using gene-set enrichment
analysis to identify only those genes present in the human
signature that were also upregulated during the differenti-
ation of mouse memory CD8 T cells as we have done pre-
viously [12]. This "filtering" step through a gold-standard
model of functional memory lymphocytes allowed us to
focus on a robust signature of genes characteristic of the
memory, rather than memory-phenotype, state. From this
list we selected genes that showed the highest signal-to-
noise ratio in the microarray analysis of naive and mem-
ory-phenotype CD4 T cells (Fig 2). Genes were selected to
include those upregulated in memory-phenotype CD4 T
cells compared to naive cells (Fig 2B, purple text) and
those downregulated in memory-phenotype cells com-
pared to naive cells (Fig 2B, green text). The selection of
genes that were differentially expressed in both directions
served to reduce the chance of detecting compounds that
caused indiscriminate increases or decreases in expression
of all genes in the signature.
CD4 T cells were chosen for these experiments because of
the availability of reagents for magnetic isolation of large
numbers of naive or memory-phenotype cells. It is impor-
tant to note that for these proof of principle experiments,
our test populations of lymphocytes were memory-pheno-
type cells, rather than those with known functional prop-
erties of memory lymphocytes. Unequivocally identifying
human T cells with the functional properties of memory –
such as antigen-independent survival and the ability to
self-renew – is not feasible; instead we chose a to study
cells with a well recognized memory-phenotype as this
population is presumably enriched for those cells that
have memory function. The method of purifying popula-
tions of naive and memory-phenotype cells did not influ-
ence the expression levels in the signature, and
comparison of results from cells flow-sorted or purified
with MACS were highly correlated (data not shown).
However, MACS purification allowed more rapid isola-
tion of the number of cells needed for screening applica-
tions.
Quantitation of Differentiation Signature Genes in T Cells
Gene-specific primers were designed for each of the 55
genes in the differentiation signatures and for four control
genes with which to normalize expression level data
between replicate wells. Control genes were chosen
Schema representing steps involved in ligation-mediated amplification Figure 1
Schema representing steps involved in ligation-mediated amplification.
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(ACTB, TUBB, TUBG1, and HNRPAB) that showed low
signal-to-noise ratios of expression level in Affymetrix
data between naive and memory-phenotype CD4 T cells,
and which spanned the range of expression levels seen in
the transcripts of the differentiation signature. In subse-
quent analyses each gene in the differentiation signature
was normalized to the mean of these four genes.
Naive and memory-phenotype CD4 cells were flow-sorted
using the gating strategy shown in Figure 2 and plated at
various cell densities per well in 96-well U-bottom plates.
Following cell lysis, LMA and bead-detection were per-
formed (Fig 3). All 59 genes were successfully amplified,
indicating that the method can reliably amplify a large
number of genes simultaneously. Cell titration experi-
ments demonstrated that optimal gene expression data
were obtained at cell numbers of 25,000 per well or above
(data not shown); all subsequent experiments were per-
formed using 25,000 cells/well. The absolute transcript
expression values spanned a 3-log range (Fig. 3A). The
most abundant transcripts in the memory-phenotype dif-
ferentiation signature included LGALS3 and FAS, and in
the naive differentiation signature, CCR7 and PECAM1.
However, even transcripts that would be expected to be
expressed at a low copy number such as the transcription
factors KLF10 or BACH2 were amplified reliably suggest-
ing efficient amplification of even low abundance tran-
scripts.
Comparison of expression levels of naive or memory
genes in naive and memory-phenotype cells (Fig. 3B)
showed that the difference in expression level between
naive and memory-phenotype cells was large for some
genes, such as LGALS3, ANAX1 (upregulated in memory-
phenotype compared to naive), and SATB1 and SCML1
(upregulated in naive compared with memory-pheno-
type). However, for other genes relatively small differ-
ences in expression between each cell type were observed
(e.g. KLF10 or SERPINE2). The magnitude of difference in
gene expression was not related to the overall transcript
abundance: genes such as AHNAK were expressed at high
levels but demonstrated small fold-difference in expres-
sion between effector/memory phenotype and naive cells.
However, while the difference in expression level for indi-
vidual transcripts was small for many of the genes in the
signature, the overall direction of change in expression
levels was as predicted for the majority of memory-pheno-
type marker genes and naive marker genes (Fig 3B), i.e.
the vast majority of genes expected to be higher in mem-
ory-phenotype cells were indeed expressed at higher levels
than in naive cells and vice-versa. Overall ~10% of tran-
scripts in the panel were "contrarian", or expressed at rel-
ative levels opposite to that predicted (e.g. ANXAP2,
SMA3). Such genes were not included in subsequent anal-
yses.
We reasoned that measuring multiple genes representa-
tive of a cell state would provide a more robust discrimi-
nation of cell state than relying on a single gene because
small but consistent differences in expression level of sig-
nature genes could be aggregated. To test this, the expres-
sion level of the differentiation signature genes were
measured in multiple replicates of memory-phenotype
Gene-expression profiling of naive and memory-phenotype  human CD4 T cells Figure 2
Gene-expression profiling of naive and memory-phe-
notype human CD4 T cells. (A) Peripheral blood T cells, 
gated on CD4 T cells, stained to identify naive (green gate), 
central memory (CM) or effector memory (EM) cells. (B) 
Expression profile of genes differentially expressed in naive 
and memory-phenotype CD4 T cells sorted using the gates 
shown in (A). Each row represents an individual gene, and 
each column a different sample of naive, EM or CM CD4 T 
cells from seven healthy donors. Genes upregulated in mem-
ory-phenotype cells are shown in purple, and those upregu-
lated in naive cells in green.
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and naive CD4 T cells (Fig 3C). For each well, the expres-
sion of memory-phenotype marker genes or naive marker
genes were summed (after conversion to a Z-scores to
compensate for the wide range in absolute expression val-
ues) and expressed as two vectors or "scores" on a bivari-
ate plot. The cumulative scores of expression values for
memory-phenotype or naive marker genes separate mem-
ory-phenotype (black symbols) or naive (white symbols)
CD4 T cells more clearly than does the expression level of
any of the individual transcripts.
To quantify this difference, Z' factors were calculated for
individual genes and for the summary score of expression
values of all genes. The Z' factor is used to evaluate the
ability of assays to detect true positive results in high-
throughput screens [17]. The theoretical maximum value
is 1, and values > 0.5 suggest excellent ability to detect true
positive 'hits'. In contrast, values below 0 do not allow dis-
crimination of positive and negative results. As shown in
Table 1, the Z' factor for this signature was 0.68, and the
highest score was achieved by aggregating all genes in the
differentiation signature. No single gene provided as high
resolution, and only three individual genes (S100A4,
Figure 3
Amplification of differentiation signature genes in primary  human T cells Figure 3
Amplification of differentiation signature genes in 
primary human T cells. (A) Expression level (aribrary 
units) of memory-phenotype marker genes (upper panel) or 
naive marker genes (lower panel) measured in sorted popu-
lations of naive (white bars) or memory-phenotype (black 
bars) peripheral blood CD4 T cells (25,000 cells/well). Each 
bar represents mean of ~6 replicate wells. Standard deviation 
was < 8% (not shown) in all cases. (B) Difference in expres-
sion level for naive (white bars) or memory-phenotype (black 
bars) marker genes between memory-phenotype and naive 
CD4 T cells. Values > 0 show relative increase in expression 
in memory-phenotype CD4 T cells; < 0 show relative 
increase in naive CD4 T cells. (C) Cumulative score of mem-
ory-phenotype (plotted on Y-axis) or naive marker genes (X-
axis) in effector/memory phenotype (black symbols) or naive 
(white symbols) CD4 T cells. Values expressed as Z scores 
to compensate for wide variation in expression level of indi-
vidual genes.
Table 1: Z' Factor scores for the aggregate genes in the signature 
(summary score) or for the highest scoring three individual 
genes.
Parameter Z' Factor
Weighted summary score (all genes) 0.65
S100A4 0.45
LGALS3 0.36
ANAX1 0.3
All other genes individually <0BMC Immunology 2008, 9:44 http://www.biomedcentral.com/1471-2172/9/44
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LGALS3, and ANAX1) gave Z' factors above 0. Thus the use
of a signature-based assay was superior to any single
marker gene in distinguishing naive and memory-pheno-
type CD4 T cells.
Comparison of LMA with Affymetrix gene expression 
profiling
We next considered how well the method recapitulated
the changes in gene expression measured by Affymetrix
microarrays. We compared the difference in gene expres-
sion levels between memory-phenotype and naive CD4 T
cells measured by LMA/bead-based detection with the
original Affymetrix microarray data shown in Figure 1.
The values were highly correlated between platforms (Fig
4). This is especially striking because samples from differ-
ent healthy donors were used to generate the expression
data on each platform. Thus the changes detected by LMA/
bead-based detection are similar to those measured by
Affymetrix microarray.
Differentiation signature is comparable between donors
We next evaluated the variability of the gene expression
level detection across multiple replicates of naive and
memory-phenotype CD4 T cells from two donors. Being
able to perform screens involving large numbers of com-
pounds would require pooling data from multiple
donors. To identify the extent of donor-to-donor variabil-
ity, we compared the expression levels of all genes in naive
and memory-phenotype CD4 T cells in two donors (Fig
5). The expression levels were highly correlated (Rs =
0.99), suggesting that there is little variability in the rela-
tive expression levels of this set of transcripts between
populations of phenotypically similar CD4 T cells in the
two donors studied.
Assay is precise and robust
To function as a screening tool that can be scaled up to
high-throughput, the assay should ideally be robust and
precise, even when used at high-throughput with robotic
fluid handling. We therefore performed the assay in large
numbers of replications (~100 per cell type) in CD4 T
cells obtained from a leukapheresis product from a
healthy donor.
After MACS purification of naive and memory-phenotype
CD4 T cells, cells were plated into a 384 well plate. The
cells were incubated for 18 hours (to simulate exposure to
Comparison of gene expression levels of differentiation sig- nature genes measured by different platforms Figure 4
Comparison of gene expression levels of differentia-
tion signature genes measured by different plat-
forms. Difference in expression level of naive (white 
symbols) or memory-phenotype (black symbols) marker 
genes or control genes (grey symbols) between memory-
phenotype and naive CD4 T cells. Values > 0 show relative 
increase in expression in memory-phenotype CD4 T cells; < 
0 show relative increase in naive CD4 T cells. Expression lev-
els for corresponding genes measured by LMA are plotted 
on Y axis; by Affymetrix U133A microarray on X-axis. Each 
point represents the mean values from cells sorted from ~4 
– 6 subjects. Rs and P value refer to Spearman correlation 
coefficient.
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Minimal donor variation in relative expression of differentia- tion signature in different donors Figure 5
Minimal donor variation in relative expression of dif-
ferentiation signature in different donors. Correlation 
of expression level for each transcript in naive or memory-
phenotype CD4 T cells measured by the method in two dif-
ferent healthy donors. Rs and P value refer to Spearman cor-
relation coefficient.
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test compounds), followed by harvest, LMA, and bead
detection using robotic fluid handling (Fig 6). Replicate
measurements of genes in the differentiation signature
were highly correlated, and all data points fell within two-
fold of their corresponding means (Fig 6A). The Z' Factor
for the memory-phenotype versus naive comparisons in
scaled up and automated experiments were ≥ 0.5, suggest-
ing that the assay can be performed on a scale necessary to
permit high-throughput screens.
Discussion
The ability to identify compounds that direct the cellular
differentiation of naive T cells into memory cells could
have significant therapeutic impact. However, the lack of
reporter assays suitable for high-throughput that can accu-
rately distinguish between discrete differentiation states in
T cell development has limited this approach. Here we
describe the application of a gene expression-based assay
that detects complex, multigene signatures and distin-
guishes samples of naive and memory-phenotype CD4 T
cells from human peripheral blood at high-throughput.
Traditionally, reporter gene assays measure the transcrip-
tional activity of a single gene that is characteristic of the
differentiated state. However, in the case of memory lym-
phocyte differentiation, no single gene can accurately dis-
tinguish between naive and memory-phenotype cells. For
instance, the naive markers CCR7 and CD62L are both re-
expressed by central memory cells preventing these genes
in isolation from being used to separate the two cellular
states [18]. Similarly, genes that are not expressed by naive
T cells such as granzyme B or perforin are expressed by
both effector and memory-phenotype cells making it dif-
ficult to screen for compounds that direct differentiation
only towards a memory state [11]. We took the approach
of identifying a signature of genes that are differentially
expressed during memory differentiation both in humans
and mice, regardless of their functional role. This cross-
species signature readily discriminated between the test
populations of cells in these experiments – phenotypically
naive cells that would not be expected to manifest the
memory differentiation signature, and memory-pheno-
type cells that, as a population, would be expected to
show increased expression of a memory differentiation
signature. The assay that we used simultaneously meas-
ured the expression level of a panel of 55 genes that
included transcripts increased in memory-phenotype
CD4 T cells compared to their naive counterparts and an
equivalent number that show the opposite profile. We
found that, as expected, the expression level of each gene
in isolation was often not markedly different between
naive and memory-phenotype CD4 T cells. However,
most memory-phenotype marker genes were consistently
expressed at higher levels in memory-phenotype cells
than in naive cells; similarly, naive-phenotype genes were
consistently expressed in greater abundance in naive CD4
T cells than in memory-phenotype cells. When the result-
ing, albeit small, difference in expression level of each of
a gene in the panel was aggregated, naive and memory-
phenotype cells could be easily distinguished with a Z' fac-
tor score better than any gene in isolation. This demon-
strates that a signature-based screening platform can
provide a powerful degree of resolution in distinguishing
differentiation states that lack clear-cut differentiation
markers.
We developed this assay to allow screening to be done
using primary human lymphocytes. The use of primary
human cells as starting material is highly unusual for dif-
ferentiation-based screens but offers significant advan-
tages over cell lines. The analysis of primary cells ex vivo
more closely recapitulates the cellular state in vivo than
does the analysis of cell lines. Moreover, primary cells may
be more sensitive to toxicities of compounds identified
within a screen allowing earlier detection of potentially
harmful drugs. Three factors suggest that using primary
human T cells for memory differentiation screens will
prove feasible. First, T cells are relatively abundant and
can be accessed in normal volunteers with minimal mor-
bidity. Second, selection of subsets within the peripheral
T cell compartment is technically straightforward with a
number of available cell separation techniques. Third, we
found a remarkable degree of consistency in the relative
expression level of genes in the differentiation signature
between two different donors. This fact is of great practical
significance as several different donors would be needed
to contribute naive T cells to a screen for a high-complex-
ity compound library. Further evaluation across a larger
number of normal donors will be necessary to define rig-
orously how significant an obstacle donor-to-donor vari-
ability in gene-expression will be in the conduct of large
screens spanning more than one donor. However, the lack
of donor-to-donor variability in these initial studies sug-
gests that analysis of pooled screening data from multiple
donors may be possible.
There are clearly caveats associated with a signature-based
approach to HTS in primary cells. The signature of genes
was defined empirically, and so the biological relevance of
any of the genes in the signature to the differentiation
states of interest is unknown. However, the differentiation
signature used in this study is highly evolutionarily con-
served, shared by memory differentiation in both T and B
cell lineages, and disrupted in functionally exhausted T
cells [12]. This suggests that this gene signature in toto is
highly correlated with the differentation state of func-
tional memory cells. Never-the-less, future studies will be
required to determine whether it is possible to elicit the
complex gene expression profile representative of a given
differentiation state without inducing its attendant func-BMC Immunology 2008, 9:44 http://www.biomedcentral.com/1471-2172/9/44
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Evaluation of LMA/Luminex detection assay reproducibility and scalability Figure 6
Evaluation of LMA/Luminex detection assay reproducibility and scalability. (A) Mean expression level for each tran-
script in naive or memory-phenotype CD4 peripheral blood T cells were calculated and the deviation of that data point from 
its corresponding mean were calculated. The fraction of data points in each of 12 bins of fold deviation values is shown, repre-
senting 1100 data points (two differentiation states × 55 transcripts × 6 replicates). (B) Cumulative Z-score for multiple repli-
cates of memory-phenotype (purple) or naive (green) CD4 T cells measured by the method carried out using robotic 
automation. Values > 0 show relative increase in expression of memory-phenotype signature genes; < 0 show relative increase 
of naive signature genes.
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tional properties. Second, the use of primary human cells
is technically challenging. Like all primary cells we found
that increasing time in culture altered the gene expression
profiles, presumably due to the lack of input signals from
the normal milieu found in vivo (data not shown). How-
ever, data from mouse models suggests that the lineage
commitment step for naive T cells differentiating after
antigen-encounter occurs within hours or days of initial
TCR signaling [19-22]. This suggests that a brief exposure
to compound may be sufficient to direct differentiation of
naive T cells to a memory fate before adverse ex vivo effects
are apparent in the differentiation signature.
Our data suggests that it is now possible to screen for com-
pounds that induce memory differentiation in naive
human T cells. Compounds identified in such a screen
would have significant biological and therapeutic uses.
First, as tool compounds, hits in a memory differentiation
screen could afford new insights into the mechanisms
underlying memory development. Second, as therapeutic
agents, memory-differentiating drugs could be used to
accelerate the ex-vivo expansion of antigen-specific T cells
or improve the efficiency of current vaccination
approaches. Although widescale differentiation of naive T
cells into memory cells would be undesirable in a clinical
situation, antigen-specificity on promoting memory dif-
ferentiation could be achieved by co-administration with
vaccines, by optimization of dose and/or timing, or by the
use of ex-vivo treatment of antigen-specific T cells.
Conclusion
The use of LMA with bead-based detection offers a generic
solution for T cell differentiation-based screens where no
single-gene or functional assay is available. The same
experimental platform can be easily adapted to other
screening applications by using a panel of genes specific to
the biology of interest. For instance, screens to detect the
differentiation of effector memory T cells into those with
a central memory gene expression signature could be
designed based on their different expression profiles.
Screens to convert conventional CD4 T cells into regula-
tory T cells could be developed by using a transcriptional
profile of genes differentially expressed between conven-
tional CD4 T cells and Tregs [23,24]. Similarly, screens to
identify compounds that differentiate exhausted CD8 T
cells into functional T cells can be designed using a panel
of genes representing each state [25]. Assaying primary
human T cells or mouse cells can be accommodated by
the design of species-specific probes corresponding to
orthologous genes. The ability to perform differentiation
screens in T cell immunology with previously "unscreena-
ble" phenotypes, and without the need to develop entirely
new screening assays each time could significantly acceler-
ate the discovery of compounds, genes or soluble factors
that influence the development of T cell immunity in
humans.
Methods
Research Subjects and cell purification
Peripheral blood samples were obtained from healthy
volunteers who gave informed consent for research and
were enrolled on a protocol approved by the DFCI IRB.
Written informed consent was obtained from the subjects
for publication of data in this report. A copy of the written
consent is available for review by Editor-in-Chief of this
journal. Peripheral blood mononuclear cells were puri-
fied by density centrifugation. Naive or effector/memory
phenotype CD4 T cells were obtained either by negative
selection over a magnetic column (Naive or Memory
CD4+ T cell Isolation Kit, Miltenyi Biotec) or by flow sort-
ing. For sorting, cells were stained with a cocktail of anti-
bodies designed to exclude irrelevant lineages, Annexin V
to exclude dead/dying cells, and CD4, CD45RA and
CD62L to identify memory-phenotype and naive CD4 T
cells as shown in Figure 2. Purity of MACS isolated naive
cells was routinely > 95%, and sorted cells was > 99%.
Ligation-mediated amplification
Purified populations of naive or memory-phenotype cells
were plated in 384-well tissue-culture plates at 25,000
cells per well in 50 uL of RPMI supplemented with 10%
human AB-serum (Valley Biomedical, Inc.) and antibiot-
ics, and incubated at 37°C with 5% CO2 for ~18 hours.
After incubation, 40 uL of medium was removed from the
wells with a Multimek robot (Beckman Coulter). Cells
were lysed with the addition of 10 ul of TCL lysis buffer
(Qiagen) for 20 minutes at room temperature. The lysate
was transferred to a 384-well oligo-dT coated plated (Tur-
boCapture 384 mRNA kit, Qiagen) and incubated for 1
hour at room temperature. Excess lysate was removed by
briefly centrifuging inverted uncovered plates onto
absorbent paper towel. Reverse transcription was carried
out in a 5 uL reaction volume using MMLV reverse tran-
scriptase at 37°C (Promega). After a 90 minute incuba-
tion, liquid was removed from the wells by inverted
centrifugation of the plates. Gene-specific oligonucleotide
probes (Additional file 1) were hybridized to the plate-
bound cDNA using 2 nM of each probes (118 probes in
total). Upstream probes were designed to contain a T7
primer sequence, Luminex-designed FlexMap barcode tag
(24 nucleotides in length) and the gene-specific sequence
(20 nt). Downstream probes were phosphorylated at the
5' end to allow subsequent DNA ligation, and contained
gene-specific sequence followed by a T3 primer sequence.
Gene-specific probes were designed such that the
upstream and downstream probes were of similar G-C
composition, minimal repeats, and abutted at C and G or
G and C nucleotides. Probe hybridization was performed
at 95°C for 2 minutes followed by 50°C for 1 hour. ExcessBMC Immunology 2008, 9:44 http://www.biomedcentral.com/1471-2172/9/44
Page 10 of 11
(page number not for citation purposes)
probe was removed by inverted centrifugation of the
plate. DNA ligation step was then performed using Taq
ligase (New England Biolabs) in a 5 uL volume at 45°C
for 1 h followed by incubation at 65°C for 10 minutes.
Excess ligation mix was spun out by inverted centrifuga-
tion of the plate. The ligated products were amplified with
a universal, biotinylated T3 primer (5'-ATT AAC CCT CAC
TAA AGG GA-3') and a universal T7 primer (5'-TAA TAC
GAC TCA CTA TAG GG-3') using HotStarTaq DNA
polymerase (Qiagen) in a 5 uL reaction volume.
Amplicon detection was carried out using xMAP Multi-
Analyze COOH microspheres (Luminex, 2.5 × 106) cou-
pled to FlexMap barcode sequences that were comple-
mentary to barcode sequences contained in the gene-
specific probe pairs. Coupling reactions were performed
as previously described [14]. A 5 uL aliquot of the liga-
tion-mediated amplification mix was hybridized to a mix-
ture of microspheres containing ~2500 fluorescently
distinguishable microspheres per gene in 18 uL of 1.5×
TMAC (4.5 M tetramethylammonium chloride, 0.15% N-
lauryl sarcosine, 75 mM Tris-HCl [pH 8], and 6 mM EDTA
[pH 8]) and 5 uL of TE [pH8] at 95°C for 2 min and then
45°C for 1 h. To detect the amplicon bound to each bead,
the sample was incubated with 20 ul of streptavidin-PE
(Invitrogen) in 1× TMAC for 5 min at 45°C, washed twice,
and resuspended in 1× TMAC. Dual-color fluorescence
was detected with a Luminex 200, or high-throughput
detection instruments. A minimum of 30 events was
recorded per microsphere, and the median intensity on
the PE channel recorded per bead.
Data analysis
The median fluorescence intensity of PE corresponding to
a gene-specific bead was used as a measure of the gene's
expression level. Expression levels of each signature gene
in the well were indexed to a mean of 4 control genes
(ACTB, TUBG, TUBB and HNRAPB) in the corresponding
well to minimize well-to-well variability. Filtering was
performed to eliminate wells with aberrant control gene
expression from further analysis, using the mean plus or
minus two times the standard deviation of the control
genes as a filtering threshold. Aggregate scores of all genes
in the panel created a summed score of the indexed
expression values of the memory and naive genes with a
sign determined by the expected direction of expression in
the two differentiation states. For some visualizations,
normalization of the gene expression values were per-
formed using a Z-score derived by subtracting the mean
expression level of the gene in that class from a the raw
gene expression value in a given well and then dividing
the difference by the standard deviation of the gene's
expression in that class.
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